{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:11:07Z","timestamp":1791443467016,"version":"4.3.3"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold>A major difficulty in treating moyamoya disease is the lack of effective methods to detect novel or progressive disease prior to the onset of disabling stroke. More importantly, a tool to better stratify operative candidates and quantify response to therapy could substantively complement existing methods. Here, we present proof-of-principle data supporting the use of urinary biomarkers as diagnostic adjuncts in pediatric moyamoya patients.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold>Urine and cerebrospinal fluid specimens were collected from pediatric patients with moyamoya disease and a cohort of age and sex-matched control patients. Clinical and radiographic data were paired with measurements of a previously validated panel of angiogenic proteins quantified by ELISA. Results were compared to age and sex-matched controls and subjected to statistical analyses.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold>Evaluation of a specific panel of urinary and cerebrospinal fluid biomarkers by ELISA demonstrated significant elevations of angiogenic proteins in samples from moyamoya patients compared to matched controls. ROC curves for individual urinary biomarkers, including MMP-2, MMP-9, MMP-9\/NGAL, and VEGF, showed excellent discrimination. The optimal urinary biomarker was MMP-2, providing a sensitivity of 88%, specificity of 100%, and overall accuracy of 91%. Biomarker levels changed in response to therapy and correlated with radiographic evidence of revascularization.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold>We report, for the first time, identification of a panel of urinary biomarkers that predicts the presence of moyamoya disease. These biomarkers correlate with presence of disease and can be tracked from the central nervous system to urine. These data support the hypothesis that urinary proteins are useful predictors of the presence of moyamoya disease and may provide a basis for a novel, non-invasive method to identify new disease and monitor known patients following treatment.<\/jats:p>","DOI":"10.3389\/fneur.2021.661952","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T07:07:41Z","timestamp":1617260861000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Non-invasive Urinary Biomarkers in Moyamoya Disease"],"prefix":"10.3389","volume":"12","author":[{"given":"Julie","family":"Sesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Driscoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Moses-Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren B.","family":"Orbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Zurakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1161\/STR.0000000000000183","article-title":"Management of stroke in neonates and children: a scientific statement from the American Heart Association\/American Stroke Association","volume":"50","author":"Ferriero","year":"2019","journal-title":"Stroke J Cereb Circ."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMra0804622","article-title":"Moyamoya disease and moyamoya syndrome","volume":"360","author":"Scott","year":"2009","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s12276-020-0414-0","article-title":"Dysregulation of the EphrinB2-EphB4 ratio in pediatric cerebral arteriovenous malformations is associated with endothelial cell dysfunction in vitro and functions as a novel noninvasive biomarker in patients","volume":"52","author":"Fehnel","year":"2020","journal-title":"Exp Mol Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1158\/1078-0432.CCR-07-1253","article-title":"Urinary biomarkers predict brain tumor presence and response to therapy","volume":"14","author":"Smith","year":"2008","journal-title":"Clin Cancer Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"E1148","DOI":"10.1227\/01.NEU.0000255464.37634.3C","article-title":"A recurrent craniopharyngioma illustrates the potential usefulness of urinary matrix metalloproteinases as noninvasive biomarkers: case report","volume":"60","author":"Smith","year":"2007","journal-title":"Neurosurgery."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1158\/0008-5472.CAN-13-3116","article-title":"Netrin-1 promotes medulloblastoma cell invasiveness and angiogenesis, and demonstrates elevated expression in tumor tissue and urine of patients with pediatric medulloblastoma","volume":"74","author":"Akino","year":"2014","journal-title":"Cancer Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3171\/2016.9.PEDS16161","article-title":"Preoperative transdural collateral vessels in moyamoya as radiographic biomarkers of disease","volume":"19","author":"Storey","year":"2017","journal-title":"J Neurosurg Pediatr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/dmcn.12708","article-title":"Moyamoya: defining current knowledge gaps","volume":"57","author":"Ganesan","year":"2015","journal-title":"Dev Med Child Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3340\/jkns.2015.57.6.415","article-title":"Moyamoya Biomarkers","volume":"57","author":"Smith","year":"2015","journal-title":"J Korean Neurosurg Soc."},{"key":"B10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/neuonc\/noaa016","article-title":"A phase I\/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study","volume":"22","author":"Baxter","year":"2020","journal-title":"Neuro Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/(SICI)1097-4644(19960301)60:3<379::AID-JCB9>3.0.CO;2-T","article-title":"Temporal study of the activity of matrix metalloproteinases and their endogenous inhibitors during wound healing","volume":"60","author":"Moses","year":"1996","journal-title":"J Cell Biochem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"S238","DOI":"10.1016\/S0303-8467(97)00082-6","article-title":"Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan","volume":"99","author":"Fukui","year":"1997","journal-title":"Clin Neurol Neurosurg."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04698-7","article-title":"Serum vascular endothelial growth factor (VEGF) levels in ischemic stroke patients: a systematic review and meta-analysis of case-control studies","author":"Seidkhani-Nahal","year":"2020","journal-title":"Neurol Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jpeds.2009.10.034","article-title":"Biomarkers of hypercoagulability and inflammation in childhood-onset arterial ischemic stroke","volume":"156","author":"Bernard","year":"2010","journal-title":"J Pediatr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1161\/01.STR.32.8.1759","article-title":"Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment","volume":"32","author":"Montaner","year":"2001","journal-title":"Stroke."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.ejca.2005.03.032","article-title":"REporting recommendations for tumour MARKer prognostic studies (REMARK)","volume":"41","author":"McShane","year":"2005","journal-title":"Eur J Cancer."},{"key":"B17","first-page":"194","article-title":"Comparing groups, continuous data","volume-title":"Practical Statistics for Medical Research","author":"Altman","year":"1991"},{"key":"B18","first-page":"45","article-title":"Frequency","volume-title":"Clinical Epidemiology: The Essentials","author":"Fletcher","year":"2005"},{"key":"B19","first-page":"1071","article-title":"Regression models for prognostic prediction: advantages, problems, and suggested solutions","volume":"69","author":"Harrell","year":"1985","journal-title":"Cancer Treat Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2307\/2529990","article-title":"A simple approximation for calculating sample sizes for comparing independent proportions","volume":"36","author":"Fleiss","year":"1980","journal-title":"Biometrics."},{"key":"B21","first-page":"1395","article-title":"Increased incidence of matrix metalloproteinases in urine of cancer patients","volume":"58","author":"Moses","year":"1998","journal-title":"Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s11060-004-2752-5","article-title":"Genetic and hypoxic regulation of angiogenesis in gliomas","volume":"70","author":"Kaur","year":"2004","journal-title":"J Neurooncol."},{"key":"B23","first-page":"1649","article-title":"Recent advances in the treatment of pediatric brain tumors","volume":"18","author":"Gururangan","year":"2004","journal-title":"Oncology (Huntingt)."},{"key":"B24","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1081\/CNV-200027141","article-title":"Progress report on the potential of angiogenesis inhibitors for neuro-oncology","volume":"22","author":"Purow","year":"2004","journal-title":"Cancer Invest."},{"key":"B25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/156720206778018730","article-title":"New vessel formation in the central nervous system during tumor growth, vascular malformations, and Moyamoya","volume":"3","author":"Lim","year":"2006","journal-title":"Curr Neurovasc Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.surneu.2008.10.009","article-title":"Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease","volume":"72","author":"Fujimura","year":"2009","journal-title":"Surg Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"882","DOI":"10.3171\/jns.2005.103.5.0882","article-title":"Enhanced brain angiogenesis in chronic cerebral hypoperfusion after administration of plasmid human vascular endothelial growth factor in combination with indirect vasoreconstructive surgery","volume":"103","author":"Kusaka","year":"2005","journal-title":"J Neurosurg."},{"key":"B28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000121249","article-title":"Elevation of cerebrospinal fluid levels of basic fibroblast growth factor in moyamoya and central nervous system disorders","volume":"27","author":"Malek","year":"1997","journal-title":"Pediatr Neurosurg."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1161\/01.STR.0000148237.13659.e6","article-title":"Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease","volume":"35","author":"Nanba","year":"2004","journal-title":"Stroke."},{"key":"B30","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/jnnp.2009.191817","article-title":"Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease","volume":"81","author":"Kang","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B31","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/mrd.20196","article-title":"Matrix metalloproteinase-2 (MMP-2) expression and regulation by tumor necrosis factor alpha (TNF\u03b1) in the bovine corpus luteum","volume":"70","author":"Zhang","year":"2004","journal-title":"Mol Reprod Dev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1097\/01.TP.0000137935.81103.A2","article-title":"Urinary matrix metalloproteinases and their endogenous inhibitors predict hepatic regeneration after murine partial hepatectomy","volume":"78","author":"Greene","year":"2004","journal-title":"Transplantation."},{"key":"B33","doi-asserted-by":"publisher","first-page":"849","DOI":"10.2527\/1996.744849x","article-title":"Identification of matrix metalloproteinases and metalloproteinase inhibitors in bovine corpora lutea and their variation during the estrous cycle","volume":"74","author":"Goldberg","year":"1996","journal-title":"J Anim Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1477-7827-1-85","article-title":"Temporal and spatial expression of tissue inhibitors of metalloproteinases 1 and 2 (TIMP-1 and\u22122) in the bovine corpus luteum","volume":"1","author":"Zhang","year":"2003","journal-title":"Reprod Biol Endocrinol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"40989","DOI":"10.1074\/jbc.M306176200","article-title":"Structural and functional uncoupling of the enzymatic and angiogenic inhibitory activities of tissue inhibitor of metalloproteinase-2 (TIMP-2): loop 6 is a novel angiogenesis inhibitor","volume":"278","author":"Fernandez","year":"2003","journal-title":"J Biol Chem."},{"key":"B36","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1242\/jcs.113.22.3979","article-title":"Adhesion-dependent control of matrix metalloproteinase-2 activation in human capillary endothelial cells","volume":"113","author":"Yan","year":"2000","journal-title":"J Cell Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1200\/JCO.2004.07.022","article-title":"Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy","volume":"22","author":"Chan","year":"2004","journal-title":"J Clin Oncol."},{"key":"B38","first-page":"2207","article-title":"Radiation therapy to a primary tumor accelerates metastatic growth in mice","volume":"61","author":"Camphausen","year":"2001","journal-title":"Cancer Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/S0360-3016(02)03449-1","article-title":"Radiation abscopal antitumor effect is mediated through p53","volume":"63","author":"Camphausen","year":"2003","journal-title":"Cancer Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1542\/peds.2004-1518","article-title":"Increased expression of urinary matrix metalloproteinases parallels the extent and activity of vascular anomalies","volume":"116","author":"Marler","year":"2005","journal-title":"Pediatrics."},{"key":"B41","doi-asserted-by":"publisher","first-page":"37258","DOI":"10.1074\/jbc.M106089200","article-title":"The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B\/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL","volume":"276","author":"Yan","year":"2001","journal-title":"J Biol Chem"},{"key":"B42","doi-asserted-by":"publisher","first-page":"51323","DOI":"10.1074\/jbc.M409565200","article-title":"ADAM 12 Cleaves extracellular matrix proteins and correlates with cancer status and stage","volume":"279","author":"Roy","year":"2004","journal-title":"J Biol Chem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"5390","DOI":"10.1158\/1078-0432.CCR-04-2391","article-title":"The matrix metalloproteinase-9\/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients","volume":"11","author":"Fernandez","year":"2005","journal-title":"Clin Cancer Res."},{"key":"B44","first-page":"5731","article-title":"HIF-1\u03b1-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis","volume":"61","author":"Fang","year":"2001","journal-title":"Cancer Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/978-3-0348-7001-6_23","article-title":"Metalloproteinase inhibition as a mechanism for the inhibition of angiogenesis","volume":"61","author":"Moses","year":"1992","journal-title":"Exs."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0074-7696(08)62495-X","article-title":"The role of growth factors in vascular cell development and differentiation","volume":"161","author":"Moses","year":"1995","journal-title":"Int Rev Cytol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1073\/pnas.022630199","article-title":"Reactive oxygen generated by Nox1 triggers the angiogenic switch","volume":"99","author":"Arbiser","year":"2002","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B48","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/0304-3940(93)90416-I","article-title":"The cerebrospinal fluid in patients with moyamoya disease (spontaneous occlusion of the circle of Willis) contains high level of basic fibroblast growth factor","volume":"160","author":"Takahashi","year":"1993","journal-title":"Neurosci Lett."},{"key":"B49","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3171\/2015.12.PEDS15448","article-title":"Using urinary bFGF and TIMP3 levels to predict the presence of juvenile pilocytic astrocytoma and establish a distinct biomarker signature","volume":"18","author":"Pricola Fehnel","year":"2016","journal-title":"J Neurosurg Pediatr."},{"key":"B50","first-page":"839","article-title":"Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis","volume":"7","author":"Ino","year":"2001","journal-title":"Clin Cancer Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1056\/NEJMoa0707064","article-title":"Use of multiple biomarkers to improve the prediction of death from cardiovascular causes","volume":"358","author":"Zethelius","year":"2008","journal-title":"N Engl J Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jstrokecerebrovasdis.2008.04.006","article-title":"Inflammation and hemostasis biomarkers for predicting stroke in postmenopausal women: the Women's Health Initiative Observational Study","volume":"17","author":"Kaplan","year":"2008","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2174\/1566523033347561","article-title":"Gene therapy for ischemic brain diseases","volume":"3","author":"Saitoh","year":"2003","journal-title":"Curr Gene Ther."},{"key":"B54","doi-asserted-by":"publisher","first-page":"135357","DOI":"10.1155\/2014\/135357","article-title":"Prognostic value of VEGF in patients submitted to percutaneous coronary intervention","volume":"2014","author":"Ramos","year":"2014","journal-title":"Dis Markers."},{"key":"B55","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2143\/AC.64.3.2038029","article-title":"The influence of rosuvastatin therapy and percutaneous coronary intervention on angiogenic growth factors in coronary artery disease patients","volume":"64","author":"Semenova","year":"2009","journal-title":"Acta Cardiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ygyno.2011.07.034","article-title":"Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels","volume":"123","author":"Coticchia","year":"2011","journal-title":"Gynecol Oncol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.3171\/2009.01.FOCUS08307","article-title":"Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome","volume":"26","author":"Smith","year":"2009","journal-title":"Neurosurg Focus."},{"key":"B58","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3171\/2014.12.PEDS14563","article-title":"Down syndrome and moyamoya: clinical presentation and surgical management","volume":"16","author":"See","year":"2015","journal-title":"J Neurosurg Pediatr"},{"key":"B59","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1227\/NEU.0b013e31827b9beb","article-title":"Prevalence and characteristics of concurrent down syndrome in patients with moyamoya disease","volume":"72","author":"Kainth","year":"2013","journal-title":"Neurosurgery."},{"key":"B60","doi-asserted-by":"publisher","first-page":"6195","DOI":"10.1038\/s41598-019-42643-7","article-title":"ITGA2 as a potential nanotherapeutic target for glioblastoma","volume":"9","author":"Guo","year":"2019","journal-title":"Sci Rep."},{"key":"B61","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/cyto.a.23848","article-title":"Quantitative analysis of different cell entry routes of actively targeted nanomedicines using imaging flow cytometry","volume":"95","author":"Guo","year":"2019","journal-title":"Cytometry A."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.661952\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T22:47:37Z","timestamp":1619822857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.661952\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":61,"alternative-id":["10.3389\/fneur.2021.661952"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.661952","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"article-number":"661952"}}